Saltar ao contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Title
Autor
Subject
Número de Clasificación
ISBN/ISSN
Tag
Buscar
Avanzado
The use of individualized tumo...
Citar
Text this
Enviar este rexistro por email
Imprimir
Exportar rexistro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Permanent link
The use of individualized tumor response testing in treatment selection: Second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry
Show other versions (1)
Detalles Bibliográficos
Main Authors:
Matutes, E
,
Bosanquet, A
,
Wade, R
,
Richards, S
,
Else, M
,
Catovsky, D
Formato:
Journal article
Idioma:
English
Publicado:
2013
Existencias
Descripción
Other Versions (1)
Títulos similares
Staff View
Títulos similares
The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry.
por: Matutes, E, et al.
Publicado: (2013)
Quality of life in the LRF CLL4 trial.
por: Else, M, et al.
Publicado: (2005)
Prognostic factors in the UK LRF CLL4 trial
por: Oscier, D, et al.
Publicado: (2006)
The lack of survival differences in randomised trials in CLL may be related to the effect of second line therapies. A report from the LRF CLL4 trial.
por: Catovsky, D, et al.
Publicado: (2006)
Quality of life in the UK LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group)
por: Else, M, et al.
Publicado: (2006)